ATEZOLIZUMAB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,262 adverse event reports in the FDA FAERS database where ATEZOLIZUMAB was used for Lung neoplasm malignant.
Most Reported Side Effects for ATEZOLIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,591 | 10.7% | 3,591 | 457 |
| Off label use | 2,340 | 6.9% | 769 | 611 |
| Disease progression | 1,828 | 5.4% | 815 | 355 |
| Pyrexia | 1,599 | 4.7% | 261 | 1,096 |
| Diarrhoea | 1,490 | 4.4% | 327 | 798 |
| Fatigue | 1,253 | 3.7% | 296 | 504 |
| Anaemia | 1,195 | 3.6% | 237 | 695 |
| Pneumonia | 1,036 | 3.1% | 382 | 698 |
| Nausea | 953 | 2.8% | 219 | 498 |
| Dyspnoea | 938 | 2.8% | 290 | 614 |
| Decreased appetite | 928 | 2.8% | 233 | 436 |
| Hypothyroidism | 881 | 2.6% | 114 | 202 |
| Febrile neutropenia | 872 | 2.6% | 148 | 641 |
| Pneumonitis | 842 | 2.5% | 243 | 416 |
| Asthenia | 821 | 2.4% | 262 | 389 |
Other Indications for ATEZOLIZUMAB
Hepatocellular carcinoma (8,443)
Non-small cell lung cancer (4,459)
Small cell lung cancer (2,107)
Product used for unknown indication (1,888)
Small cell lung cancer extensive stage (1,398)
Triple negative breast cancer (1,393)
Lung adenocarcinoma (1,032)
Non-small cell lung cancer metastatic (870)
Transitional cell carcinoma (788)
Ovarian cancer (519)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)